Lineage Cell Therapeutics, Inc.
LCTX- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000876343
No open-market purchases or sales by Lineage Cell Therapeutics, Inc. insiders were filed in the last 90 days; 131 institutions reported holding it in 13F filings for Q2 2026, worth $152.7M in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding Lineage Cell Therapeutics, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Of which not filed for Q3 2021 | Q3 2021 | Change |
|---|---|---|---|---|
| Holders | 115 | 1 | 115 | +1 |
| Shares | 73.1M | 17.0K | 75.8M | +2.70M (+3.7%) |
| Value | $208.5M | $48.0K | $191.7M | −$16.7M (−8.0%) |
1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (15)
Institutions that held Lineage Cell Therapeutics, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Rafferty Asset Management, LLC | 193,756 | $488.0K | 0.00% |
| Lincoln National Corp | 154,600 | $390.0K | 0.01% |
| AQR Capital Management LLC | 100,927 | $254.0K | 0.00% |
| Two Sigma Securities, LLC | 96,762 | $244.0K | 0.05% |
| SG Americas Securities, LLC | 75,780 | $191.0K | 0.00% |
| Millennium Management LLC | 19,425 | $49.0K | 0.00% |
| Morgan Jess S & Co Inc | 15,000 | $38.0K | 0.03% |
| Sightline Wealth Advisors, LLC | 14,958 | $38.0K | 0.03% |
| Group One Trading, L.P. | 13,807 | $35.0K | 0.00% |
| Prudential Financial Inc | 11,300 | $28.0K | 0.00% |
| E Fund Management Co., Ltd. | 11,095 | $28.0K | 0.00% |
| LVM Capital Management Ltd | 10,000 | $25.0K | 0.00% |
| O'Dell Group, LLC | 2,000 | $5.00K | 0.00% |
| Community Bank, N.A. | 508 | $1.00K | 0.00% |
| Gerber Kawasaki Wealth & Investment Management | 1 | – | – |
Sold out (14)
Institutions that held Lineage Cell Therapeutics, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Marshall Wace, LLP | 186,940 | $533.0K |
| Virtu Financial LLC | 54,131 | $154.0K |
| Cubist Systematic Strategies, LLC | 47,500 | $135.0K |
| Quilter Plc | 24,873 | $70.0K |
| Paradigm, Strategies in Wealth Management, LLC | 19,775 | $56.0K |
| Wealth Architects, LLC | 17,500 | $50.0K |
| Wolverine Trading, LLC | 13,482 | $40.0K |
| Pinz Capital Management, LP | 9,100 | $26.0K |
| Credential Qtrade Securities Inc. | 2,920 | $8.29K |
| US Bancorp | 9 | $0 |
| Credit Agricole S A | 58 | $0 |
| Global Retirement Partners, LLC | 9 | $0 |
| Iron Horse Wealth Management, LLC | 110 | $0 |
| McClarren Financial Advisors, Inc. | 58 | $0 |
Not filed for Q3 2021 yet (1)
Institutions that held Lineage Cell Therapeutics, Inc. at the end of Q2 2021 and haven't filed a 13F for Q3 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Bel Air Investment Advisors LLC | 17,000 | $48.0K |